Lanean...
SA-4-1BBL as a Novel Adjuvant for the Development of Therapeutic Cancer Vaccines
Tumor associated antigen (TAA)-based therapeutic vaccines have great potential as a safe, practical, and cost-efficient alternative to standard treatments for cancer. Clinical efficacy of TAA-based vaccines, however, has yet to be realized and will require adjuvants with pleiotropic functions on imm...
Gorde:
| Argitaratua izan da: | Expert Rev Vaccines |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4721633/ https://ncbi.nlm.nih.gov/pubmed/24521311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14760584.2014.880340 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|